Immediate Clinical Complications Occurring During Membrane Change in Patients on Veno-Venous Extracorporeal Membrane Oxygenation.
Journal
ASAIO journal (American Society for Artificial Internal Organs : 1992)
ISSN: 1538-943X
Titre abrégé: ASAIO J
Pays: United States
ID NLM: 9204109
Informations de publication
Date de publication:
25 Jul 2024
25 Jul 2024
Historique:
medline:
26
7
2024
pubmed:
26
7
2024
entrez:
25
7
2024
Statut:
aheadofprint
Résumé
The clinical tolerance of extracorporeal membrane oxygenation (ECMO) membrane changes in acute respiratory distress syndrome (ARDS) patients under veno-venous ECMO (VV-ECMO) has not been reported. The aim of this study was to describe the tolerance of membrane change. Patients requiring VV-ECMO were retrospectively included between March 2020 and May 2022. In case of membrane dysfunction or an increase in hemolysis markers or an alteration in gas exchange, a membrane change was performed. The primary outcome was a composite measure defined as the occurrence of at least one of the following events within 1 hour of membrane change: severe hypoxemia, hemodynamic collapse, bradycardia, arrhythmia, cardiac arrest, and death. During the study period, 70 patients required a VV-ECMO, 29 (41%) of whom died. Thirty-two patients required a membrane change for a total of 56 changes. The primary outcome occurred for 33 (59%) changes. Arterial desaturation <80% occurred for all complicated membrane changes and cardiac arrest concerned nine changes (16%). Low tidal volume (VT), respiratory system compliance (Crs), PaO2, and high ECMO blood flow (QECMO) were associated with poor tolerance of membrane change. Threshold values of 130 ml for VT, 9.3 cm H2O for Crs, 72 mm Hg for PaO2, and 3.65 L/minute for QECMO best determined the risk of poor tolerance of membrane change.
Identifiants
pubmed: 39052935
doi: 10.1097/MAT.0000000000002270
pii: 00002480-990000000-00530
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the ASAIO.
Déclaration de conflit d'intérêts
Disclosures: The authors have no conflicts of interest to report.
Références
Tonna JE, Abrams D, Brodie D, et al.: Management of adult patients supported with venovenous extracorporeal membrane oxygenation (VV ECMO): Guideline from the extracorporeal life support organization (ELSO). ASAIO J 67: 601–610, 2021.
Combes A, Hajage D, Capellier G, et al.; EOLIA Trial Group, REVA, and ECMONet: Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. N Engl J Med 378: 1965–1975, 2018.
Nunez JI, Gosling AF, O’Gara B, et al.: Bleeding and thrombotic events in adults supported with venovenous extracorporeal membrane oxygenation: An ELSO registry analysis. Intensive Care Med 48: 213–224, 2022.
Masi P, Hékimian G, Lejeune M, et al.: Systemic inflammatory response syndrome is a major contributor to COVID-19-associated coagulopathy: Insights from a prospective, single-center cohort study. Circulation 142: 611–614, 2020.
Kalbhenn J, Schlagenhauf A, Rosenfelder S, Schmutz A, Zieger B: Acquired von Willebrand syndrome and impaired platelet function during venovenous extracorporeal membrane oxygenation: Rapid onset and fast recovery. J Heart Lung Transplant 37: 985–991, 2018.
Jiritano F, Serraino GF, ten Cate H, et al.: Platelets and extra-corporeal membrane oxygenation in adult patients: A systematic review and meta-analysis. Intensive Care Med 46: 1154–1169, 2020.
Doyle AJ, Hunt BJ: Current understanding of how extracorporeal membrane oxygenators activate haemostasis and other blood components. Front Med 5: 352, 2018.
McMichael ABV, Ryerson LM, Ratano D, Fan E, Faraoni D, Annich GM: 2021 ELSO adult and pediatric anticoagulation guidelines. ASAIO J 68: 303–310, 2022.
Vasques F, Sanderson B, Correa G, et al.: Prevalence and indications for oxygenator circuit replacement in patients receiving venovenous extracorporeal membrane oxygenation. ASAIO J 69: 849–855, 2023.
Nagler B, Hermann A, Robak O, et al.: Incidence and etiology of system exchanges in patients receiving extracorporeal membrane oxygenation. ASAIO J 67: 776–784, 2021.
Zakhary B, Vercaemst L, Mason P, Antonini MV, Lorusso R, Brodie D: How I approach membrane lung dysfunction in patients receiving ECMO. Crit Care 24: 671, 2020.
Combes A, Schmidt M, Hodgson CL, et al.: Extracorporeal life support for adults with acute respiratory distress syndrome. Intensive Care Med 46: 2464–2476, 2020.
Genty T, Burguburu S, Imbert A, et al.: Circuit change during extracorporeal membrane oxygenation: Single-center retrospective study of 48 changes. Crit Care 27: 219, 2023.
Hoffman KR, Diehl A, Paul E, Burrell AJC: The hematological effects of extracorporeal membrane oxygenator exchange. ASAIO J 69: e308–e314, 2023.
Jaber S, Rollé A, Godet T, et al.; STYLETO Trial Group: Effect of the use of an endotracheal tube and stylet versus an endotracheal tube alone on first-attempt intubation success: A multicentre, randomised clinical trial in 999 patients. Intensive Care Med 47: 653–664, 2021.
Valentin S, Amalric M, Granier G, et al.: Prognostic value of respiratory compliance course on mortality in COVID-19 patients with vv-ECMO. Ann Intensive Care 13: 54, 2023.
Assouline B, Combes A, Schmidt M: Setting and monitoring of mechanical ventilation during venovenous ECMO. Crit Care 27: 95, 2023.
Udi J, Lang CN, Zotzmann V, et al.: Incidence of barotrauma in patients with COVID-19 pneumonia during prolonged invasive mechanical ventilation—A case-control study. J Intensive Care Med 36: 477–483, 2021.
Mekontso Dessap A, Papazian L, Schaller M, et al.: Inhaled nitric oxide in patients with acute respiratory distress syndrome caused by COVID-19: Treatment modalities, clinical response, and outcomes. Ann Intensive Care 13: 57, 2023.
Rother RP, Bell L, Hillmen P, Gladwin MT: The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: A novel mechanism of human disease. JAMA 293: 1653–1662, 2005.
Schmidt M, Tachon G, Devilliers C, et al.: Blood oxygenation and decarboxylation determinants during venovenous ECMO for respiratory failure in adults. Intensive Care Med 39: 838–846, 2013.
Martucci G, Schmidt M, Agerstrand C, et al.; International ECMO Network (ECMONet): Transfusion practice in patients receiving VV ECMO (PROTECMO): A prospective, multicentre, observational study. Lancet Respir Med 11: 245–255, 2023.